IL6 and COVID-19: The expression of Zonulin, a protein that regulates tight junction formation in the GIT, is reported to increase the levels of the inflammation marker IL6 and is associated with impaired intestinal barrier function in COVID-19 patients; that also exhibit an increased rate of mortality (Giron et al., 2021).